Sam Patient Engagement Reveals Huge Unmet Need
New research presented by Steritas at ACR Convergence 2025 (ACR) reveals something striking: patients are engaging 10 times longer than the global average, trying to understand steroid side effects. ...
In Conversation With… Professor Paul Brogan, MBBS MRCP
"Kids aren't small adults. You have to score growth, puberty, and neurodevelopment, and weigh a symptom's impact differently in a two-year-old versus a fourteen-year-old." When Professor Paul Brogan ...
Steroids and Autism: What Large Cohorts and Randomized Trials Do, and Don't, Tell Us
When pregnancy complications threaten preterm delivery, clinicians routinely counsel expectant mothers about the use of steroids, medications that accelerate fetal lung maturation and reduce ...
In Conversation With… Marc Judson, MD
“If the issue were just to treat sarcoidosis, I would put everyone on 40 milligrams of prednisone, and every granuloma would be destroyed. But I'm not treating sarcoidosis disease. I'm treating the ...
Pulmonary Sarcoidosis Trial Flips the Playbook
A multicenter Dutch randomized trial published in the New England Journal of Medicine has shown that methotrexate can be used to replace prednisone as first-line therapy for symptomatic pulmonary ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
